• Exchange: Frankfurt
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharmaceuticals

Vectura Group PLC

+ Add to Watchlist


1.713 EUR 0.062 3.49%

As of 02:04:11 ET on 07/11/2014.

Snapshot for Vectura Group PLC (V4T)

Open: 1.713 Day's Range: 1.713 - 1.713 Volume: 0
Previous Close: 1.775 52wk Range: 0.864 - 2.200 1-Yr Rtn: +93.34%

Stock Chart for V4T

No chart data available.
  • V4T:GR 1.713
  • 1M
  • 1Y
Interactive V4T Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for V4T

Current P/E Ratio (ttm) -
Estimated P/E(03/2015) 680.8256
Relative P/E vs. DAX -
Earnings Per Share (GBP) (ttm) -
Est. EPS (GBP) (03/2015) 0.0020
Est. PEG Ratio -
Market Cap (M EUR) 688.05
Shares Outstanding (M) 401.66
30 Day Average Volume 0
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 11/18/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for V4T

  • Revenue
  • Net Income (M/GBP)
  • Profit Margin (%)

Company Profile & Key Executives for V4T

Vectura Group PLC develops inhaled therapies for the treatment of respiratory diseases. The Company's main products are used to treat asthma and chronic obstructive pulmonary disease. Vectura also develops products for lung pathologies and non-respiratory diseases.

Christopher Paul Blackwell "Chris"CEO/Executive DirectorPaul OliverCFO/Secretary
Trevor Michael PhillipsPresident:US Ops/COOTimothy Wright "Tim"Director:Commercial
More Company Profile & Key Executives for V4T

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Sponsored Links
sec ||= nil